Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Key Market Size Shifts in the Deep Vein Thrombosis Market: A Historical Perspective and beyond
The market size for deep vein thrombosis has consistently expanded over the past few years. It is projected to escalate from $1.06 billion in 2024 to $1.1 billion in 2025, with a compound annual growth rate (CAGR) of 4.1%.
The growth during the historic period can be credited to the enhancement in vascular medicine specialization, the sway of medical guidelines, emphasis on the prevention of thrombosis, advancement in clinical research, and heightened awareness about diagnosis.
The market size for deep vein thrombosis is anticipated to experience consistent growth in the coming years, increasing to “$1.32 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The expansion during the projected period is owed to factors such as an increasing elderly population, a surge in occurrences of lifestyle-related diseases, a focus on preventive healthcare, innovative treatment methods, and the emphasis on patient-focused care.
The forecast period will also see major trends such as heightened awareness of risk factors, progress in diagnostic procedures, innovations in treatments, public health campaigns, and prevention after surgery.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….6&type=smp
What’s Driving the Continued Growth of the Global Deep Vein Thrombosis Market?
The surge in individuals needing treatment for deep vein thrombosis (DVT) is projected to stimulate the expansion of the DVT market. DVT treatment involves using medications such as anticoagulants to hinder the creation of new blood clots and stop existing ones from enlarging, thereby relieving the condition.
This uptick in patients needing DVT treatment indicates a rise in the incidence of DVT, necessitating products for its diagnosis, prevention, and treatment. For example, the Centers for Disease Control and Prevention (CDC), a national public health body in the US, reported in February 2023 that around 900,000 individuals in the US could be impacted by DVT annually, and 60,000 to 100,000 Americans die each year due to DVT or PE (pulmonary embolism).
Hence, the growing quantity of individuals requiring treatment for deep vein thrombosis (DVT) is propelling the market.
Top Revenue-Generating Segments in the Deep Vein Thrombosis Market
The deep vein thrombosis market covered in this report is segmented –
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
Subsegments:
1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin
2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems
3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Trends Will Guide the Development Path of the Deep Vein Thrombosis Industry?
Innovations in products are becoming an increasingly prevalent trend in the deep vein thrombosis market. Major market participants are adopting pioneering technologies to create new products and maintain their market standing.
For example, in January 2023, Penumbra Inc., a company based in the US known for its innovative therapies, rolled out Lightning Flash. This is a powerful, advanced mechanical thrombectomy system for the treatment of venous and pulmonary thrombus.
With Penumbra’s cutting-edge lighting-intelligent aspiration technology and breakthrough dual clot detection algorithms, the system is engineered to swiftly remove extensive blood clots, including venous thrombus and pulmonary emboli (PE). This offers doctors a more efficiently operating, high torque-able, larger catheter designed to remove significant clot burdens in the pulmonary arteries or deep venous system, all while maintaining an exceptional safety record.
How Are Different Regions Contributing to the Deep Vein Thrombosis Market’s Growth?
North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…6&type=smp
Which Firms Are Setting the Benchmark in the Global Deep Vein Thrombosis Market?
Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.
Purchase the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=10616
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach Out to Us
Speak With Our Expert:
Saumya Sahay
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 3156230293
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
The Business Research Company – http://www.thebusinessresearchcompany.com
Follow Us On:
* LinkedIn: in.linkedin.com/company…ch-company
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information:
http://www.thebusinessresearchcompany.com/report/…ket-report http://www.thebusinessresearchcompany.com/sample….6&type=smp http://www.thebusinessresearchcompany.com/customi…6&type=smp http://www.thebusinessresearchcompany.com/purchas…x?id=10616 in.linkedin.com/company…ch-company
